Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Med J Malaysia ; 74(2): 109-115, 2019 04.
Article in English | MEDLINE | ID: mdl-31079120

ABSTRACT

INTRODUCTION: Organ donation rate in Malaysia is amongst the lowest in the World. Healthcare professionals (HCPs) working in critical care areas play an important role in the deceased organ donation (DOD) process. This study seeks to identify the demographics of HCPs working in the critical care areas and their knowledge and attitudes toward the DOD process. METHOD: A cross-sectional survey on the demographics, knowledge and attitudes of the doctors and nurses working in critical care areas was undertaken by the random sampling method, using a validated, structured questionnaire. HCP's knowledge and attitudes towards brain death (BD), DOD, organ transplantation (OT), and possession of organ donor card were compared against their demographics. RESULTS: Four hundred and twelve (72.9%) out of the total 565 HCPs in critical care areas responded of whom 163 (39.6%) were doctors and 249 (60.4%) were nurses. After adjusting for other factors, department of work and profession were highly correlated with the overall knowledge score (p<0.001 and p=0.003 respectively) and knowledge about BD (p<0.001 and p=0.013 respectively). HCPs from the neurosurgical intensive care unit (p<0.001) and doctors (p<0.001) had higher mean knowledge scores compared to their counterparts. Profession was most significantly correlated with having a positive attitude towards BD (p<0.001) and OT (p<0.001). CONCLUSION: Department, profession and ethnicity were the demographic characteristics that correlated with knowledge and attitudes of HCPs on organ donation. Efforts to improve DOD rates in Malaysia should include targeted interventions to address the knowledge and attitudes of HCPs working in critical care areas.


Subject(s)
Critical Care/statistics & numerical data , Health Knowledge, Attitudes, Practice , Health Personnel/psychology , Tertiary Care Centers/statistics & numerical data , Tissue and Organ Procurement/statistics & numerical data , Attitude of Health Personnel , Female , Health Personnel/statistics & numerical data , Humans , Male , Surveys and Questionnaires
2.
Int J Data Min Bioinform ; 7(4): 416-35, 2013.
Article in English | MEDLINE | ID: mdl-23798225

ABSTRACT

Pre-processing algorithms (PPA) and gene-selection methods (GSM) are commonly employed to select Differentially Expressed Genes (DEGs) from microarray data. Previous studies established that different combinations of PPAs and GSMs are intrinsically different in their performance to select biologically relevant DEGs. In this study, we evaluated eight combinations of PPAs and GSMs for their ability to select DEGs for prioritising gene-networks. Although the different combinations yielded dissimilar DEG-lists, all DEG-lists selected could segregate tumour from normal. Nevertheless, the DEG-list selected significantly impacted the prioritisation of cancer-associated gene-networks; hence the initial choice of PPA and GSM is crucial for subsequent interactome investigations.


Subject(s)
Gene Regulatory Networks , Neoplasms/genetics , Transcriptome , Algorithms , Humans , Protein Array Analysis
3.
Asian Pac J Cancer Prev ; 13(10): 5207-11, 2012.
Article in English | MEDLINE | ID: mdl-23244136

ABSTRACT

The present study was designed to explore the anti-cell proliferative efficacy of ferulic acid by analysing the expression pattern of cell proliferative markers, proliferating cellular nuclear antigen (PCNA) and cyclin D1, in the buccal mucosa of golden Syrian hamsters treated with 7,12-dimethylbenz(a)anthracene (DMBA). Oral squamous cell carcinomas developed in the buccal pouch of hamsters using topical application of 0.5% DMBA three times a week for 14 weeks. Immunohistochemical (PCNA) and RT-PCR (Cyclin D1) analysis revealed over expression of PCNA and cyclin D1 in the buccal mucosa of hamsters treated with DMBA alone (tumor bearing hamsters). Oral administration of ferulic acid at a dose of 40 mg/kg bw to hamsters treated with DMBA not only completely prevented the tumor formation but also down regulated the expression of PCNA and cyclin D1. The results of the present study thus suggests that ferulic acid might have inhibited tumor formation in the buccal mucosa of hamsters treated with DMBA through its anti-cell proliferative potential as evidenced by decreased expression of PCNA and cyclin D1.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene/toxicity , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Cell Transformation, Neoplastic/drug effects , Coumaric Acids/therapeutic use , Mouth Mucosa/pathology , Mouth Neoplasms/prevention & control , Neoplasms, Experimental/prevention & control , Animals , Carcinogens/toxicity , Cell Proliferation , Cricetinae , Cyclin D1/metabolism , Immunoenzyme Techniques , Male , Mesocricetus , Mouth Mucosa/drug effects , Mouth Neoplasms/chemically induced , Mouth Neoplasms/pathology , Neoplasms, Experimental/chemically induced , Neoplasms, Experimental/pathology , Proliferating Cell Nuclear Antigen/metabolism , RNA, Messenger/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
4.
Pathol Oncol Res ; 18(4): 1029-37, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22806881

ABSTRACT

The oral cancer chemopreventive efficacy of lupeol, a bioactive triterpene, was assessed by monitoring the tumor incidence and using the status of phase I and II xenobiotic metabolizing enzymes, lipid peroxidation and antioxidants as biochemical end points during 7,12-dimethylbenz(a)anthracene (DMBA) induced hamster buccal pouch carcinogenesis. Oral tumors were developed in the buccal pouch of golden Syrian hamsters by painting with 0.5 % DMBA three times a week for 14 weeks. Well differentiated oral squamous cell carcinoma with marked abnormalities in the status of biochemical markers were noticed in hamsters treated with DMBA alone. Oral administration of lupeol at a dose of 50 mg/kg bw completely inhibited the formation of oral tumors and restored the status of biochemical markers during DMBA induced oral carcinogenesis. The present study thus demonstrates the chemopreventive potential of lupeol in DMBA induced oral carcinogenesis. The chemopreventive potential of lupeol is probably due to its antioxidant or free radical scavenging property and modulating effect on phase I and II xenobiotic metabolizing enzymes in favour of the excretion of carcinogenic metabolites during DMBA induced hamster buccal pouch carcinogenesis.


Subject(s)
Anticarcinogenic Agents/pharmacology , Antioxidants/pharmacology , Mouth Neoplasms/prevention & control , Pentacyclic Triterpenes/pharmacology , 9,10-Dimethyl-1,2-benzanthracene , Animals , Cricetinae , Histocytochemistry , Incidence , Lipid Peroxidation/drug effects , Liver/drug effects , Liver/enzymology , Mesocricetus , Mouth Neoplasms/chemically induced , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , Oxidoreductases/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
5.
Asian Pac J Cancer Prev ; 13(11): 5701-8, 2012.
Article in English | MEDLINE | ID: mdl-23317242

ABSTRACT

The aim of the study was to investigate the chemopreventive potential of andrographolide in 7,12-dimethylbenz(a) anthracene (DMBA)-induced hamster buccal pouch carcinogenesis. Oral tumors developed in the buccal pouch of golden Syrian hamsters at a 100% incidence on painting with 0.5% DMBA in liquid paraffin three times a week for 14 weeks. Marked abnormalities in the status of detoxification enzymes, lipid perxodiation and antioxidants were noticed in hamsters treated with DMBA alone. Oral administration of andrographolide at a dose of 50 mg/ kg bw to hamsters treated with DMBA not only completely prevented the tumor formation but also restored the status of the above mentioned biomarkers. The present study thus demonstrates the chemopreventive potential of andrographolide in DMBA-induced hamster buccal pouch carcinogenesis, which is probably due to its antioxidant potential as well as modulating effect on xenobiotic metabolising enzymes during DMBA-induced oral carcinogenesis.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene/toxicity , Anti-Inflammatory Agents/therapeutic use , Carcinoma, Squamous Cell/drug therapy , Cell Transformation, Neoplastic/drug effects , Diterpenes/therapeutic use , Mouth Neoplasms/drug therapy , Neoplasms, Experimental/drug therapy , Animals , Antioxidants/metabolism , Carcinogens/toxicity , Carcinoma, Squamous Cell/chemically induced , Carcinoma, Squamous Cell/pathology , Catalase/metabolism , Cricetinae , Lipid Peroxidation/drug effects , Mesocricetus , Mouth Mucosa/drug effects , Mouth Mucosa/metabolism , Mouth Neoplasms/chemically induced , Mouth Neoplasms/pathology , Neoplasms, Experimental/chemically induced , Neoplasms, Experimental/pathology , Superoxide Dismutase/metabolism
6.
Asian Pac J Cancer Prev ; 13(11): 5753-7, 2012.
Article in English | MEDLINE | ID: mdl-23317251

ABSTRACT

Apoptosis, also known as cell suicide or programmed cell death, removes unwanted and genetically damaged cells from the body. Evasion of apoptosis is one of the major characteristic features of rapidly proliferating tumor cells. Chemopreventive agents inhibit or suppress tumor formation through apoptotic induction in target tissues. The aim of the present study was to investigate the pro-apoptotic potential of lupeol during 7,12-dimethylbenz(a) anthracene (DMBA) induced hamster buccal pouch carcinogenesis. Topical application of 0.5% DMBA three times a week for 14 weeks in the buccal pouches of golden Syrian hamsters resulted in oral squamous cell carcinoma. The expression pattern of apoptotic markers was analyzed using immunohistochemistry (p53, Bcl-2, Bax) and ELISA reader (caspase 3 and 9). In the present study, 100% tumor formation with defects in apoptotic markerexpression pattern was noticed in hamsters treated with DMBA alone. Oral administration of lupeol at a dose of 50 mg/kg bw completely prevented the formation oral tumors as well as decreased the expression p53 and Bcl-2, while increasing the expression of Bax and the activities of caspase 3 and 9. The present study thus indicated that lupeol might inhibit DMBA-induced oral tumor formation through its pro-apoptotic potential in golden Syrian hamsters.


Subject(s)
9,10-Dimethyl-1,2-benzanthracene/toxicity , Anti-Inflammatory Agents/pharmacology , Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/drug therapy , Cell Transformation, Neoplastic/drug effects , Mouth Neoplasms/drug therapy , Pentacyclic Triterpenes/pharmacology , Animals , Apoptosis/drug effects , Carcinogens/toxicity , Carcinoma, Squamous Cell/chemically induced , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Transformation, Neoplastic/metabolism , Cell Transformation, Neoplastic/pathology , Cricetinae , Enzyme-Linked Immunosorbent Assay , Immunoenzyme Techniques , Male , Mesocricetus , Mouth Neoplasms/chemically induced , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology
7.
Ann Oncol ; 23(4): 1010-6, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21768327

ABSTRACT

BACKGROUND: Gefitinib was demonstrated to be synergistic with cisplatin and radiotherapy (RT) in in vitro studies. Biomarkers predictive of response to gefitinib in squamous cell head and neck cancer is still lacking. METHODS: Thirty-one patients with locally advanced and easily accessible primary tumor sites for biopsies were recruited. Gefitinib was started 3 weeks before the start of cisplatin/concurrent radiotherapy (CTRT) and continued during the CTRT phase and thereafter for 4 months as consolidation phase. Two baselines and a repeat tumor sample were taken after 2 weeks of gefitinib alone to study its impact on tumor gene expression. Epidermal growth factor receptor (EGFR) protein expression, FISH and mutational status, and matrix metallopeptidase 11 (MMP11) protein expression were correlated with response and survival outcome. RESULTS: The overall response rate to gefitinib alone was 9.7%. The survival outcome is as follows: median disease free 1.3 years, median survival time 2.4 years, 3-year disease free 42.9%, and 3-year overall survival 48.4%. EGFR FISH, protein expression, and mutational status did not predict for response nor survival outcome of patients. Although MMP11 overexpression did not predict for response, it predicted significantly for a poorer survival outcome. CONCLUSIONS: Gefitinib can be combined safely with cisplatin/RT. More studies are needed to uncover predictive biomarkers of benefit to gefitinib.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor/metabolism , Chemoradiotherapy , ErbB Receptors/metabolism , Head and Neck Neoplasms/therapy , Adult , Aged , Biomarkers, Tumor/genetics , Cisplatin/administration & dosage , DNA Mutational Analysis , Disease-Free Survival , ErbB Receptors/genetics , Female , Gefitinib , Gene Expression , Gene Expression Profiling , Head and Neck Neoplasms/metabolism , Head and Neck Neoplasms/mortality , Humans , In Situ Hybridization, Fluorescence , Male , Matrix Metalloproteinase 11/genetics , Matrix Metalloproteinase 11/metabolism , Middle Aged , Oligonucleotide Array Sequence Analysis , Quinazolines/administration & dosage , Risk Factors , Smoking , Treatment Outcome
8.
Biomed Pharmacother ; 2010 Sep 21.
Article in English | MEDLINE | ID: mdl-20863648

ABSTRACT

This article has been withdrawn at the request of the author(s) and/or editor. The Publisher apologizes for any inconvenience this may cause. The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy.

9.
Eur J Med Chem ; 44(10): 3898-902, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19423197

ABSTRACT

A series of novel ether-linked bis(heterocycle)s have been synthesized via [3+2]-cycloaddition reaction of nitrile oxide with allyl alcohol followed by intramolecular 1,3-diploar cycloaddition reaction of nitrile imine with carbonyl group. All the newly synthesized compounds were screened for their anti-inflammatory and analgesic activities. Among the list of compounds (7a-k) studied, 7d, 7g, 7j, and 7k exhibited excellent activity comparable to ibuprofen and aspirin at the similar dosages.


Subject(s)
Analgesics/chemistry , Analgesics/therapeutic use , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/therapeutic use , Oxadiazoles/chemistry , Oxadiazoles/therapeutic use , Analgesics/chemical synthesis , Animals , Anti-Inflammatory Agents/chemical synthesis , Edema/chemically induced , Edema/drug therapy , Female , Male , Mice , Molecular Structure , Oxadiazoles/chemical synthesis , Pain Measurement/drug effects , Rats , Stomach/drug effects , Structure-Activity Relationship
10.
Exp Hematol ; 29(7): 894-902, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11438212

ABSTRACT

OBJECTIVE: Hematopoietic stem cells (HSCs) represent a rare and incompletely characterized fraction of marrow cells that are capable of both self-renewal and differentiation into all of the mature cells in the peripheral blood. We undertook to identify genes expressed preferentially by HSCs as an initial step toward better understanding the molecular mechanisms that underlie HSC behavior. METHODS: We modified the representational difference analysis technique to isolate gene fragments present in amplified cDNA prepared from highly purified murine hematopoietic stem/progenitor cells (Lin(-)/Hoechst(low)/rhodamine(low)) and absent (or much less abundant) in amplified cDNA prepared from lineage-committed marrow cells. We went on to use one potentially important gene fragment that we isolated in this way, to screen a cDNA library prepared from these cells and to characterize the pattern of expression of the gene in hematopoietic and other cells. RESULTS: We isolated a fragment of the homeobox transcription factor Pitx2 from amplified cDNA prepared from murine hematopoietic stem/progenitor cells. From a cDNA library prepared from these cells, a full-length cDNA was isolated that corresponds to one of the three known isoforms of Pitx2 (Pitx2c). Pitx2c is expressed in murine embryonic stem (ES) cells and in hematopoietic stem/progenitor cells but not in more differentiated hematopoietic cells or in a large panel of established murine hematopoietic cell lines. Pitx2c expression was not detected after 48 hours of in vitro cytokine stimulation of hematopoietic stem/progenitor cells. CONCLUSIONS: Pitx2c is expressed in hematopoietic stem/progenitor cells but not in their differentiated progeny. The pattern of expression of Pitx2c in primitive hematopoietic stem/progenitor cells suggests that it may play a role in hematopoietic stem-cell biology.


Subject(s)
Hematopoietic Stem Cells/physiology , Homeodomain Proteins/genetics , Nuclear Proteins , Transcription Factors/genetics , Animals , Cell Differentiation/genetics , Cell Lineage/genetics , Gene Expression Regulation, Developmental , Hematopoiesis , Mice , Mice, Inbred BALB C , Paired Box Transcription Factors , Homeobox Protein PITX2
13.
Brain Res Dev Brain Res ; 102(1): 1-12, 1997 Aug 18.
Article in English | MEDLINE | ID: mdl-9298229

ABSTRACT

Previous studies have demonstrated the critical role glutamate plays in the hypothalamus, both in the developing and adult brain. The expression of metabotropic glutamate receptor (mGluR) mRNA (mGluR1-8) was studied in the suprachiasmatic (SCN) and arcuate (ARC) nuclei. Using reverse Northern blots and cDNA-PCR, we found that all eight cloned mGluRs were expressed in these brain regions. Most had not previously been detected here. Surprisingly, this included mGluRs that had previously been thought to be restricted to the retina, such as mGluR6. We also detected, cloned, and sequenced a splice variant of mGluR7 (mGluR7b). Developmentally, the age of maximal expression of mGluRs was dependent on the region. For instance, mGluR5 was more strongly expressed in neonatal ARC than in adult, whereas the opposite was true in the SCN. Compared with P10 neonates, mGluR1, R3, R6, R7a, R7b, and R8 showed a greater expression in adult SCN and ARC.


Subject(s)
Arcuate Nucleus of Hypothalamus/metabolism , Gene Expression Regulation, Developmental/physiology , Polymerase Chain Reaction , Receptors, Metabotropic Glutamate/genetics , Suprachiasmatic Nucleus/metabolism , Amino Acid Sequence , Animals , Animals, Newborn , Arcuate Nucleus of Hypothalamus/growth & development , Base Sequence , Blotting, Northern , Brain/metabolism , Cloning, Molecular , DNA, Complementary/biosynthesis , Molecular Sequence Data , RNA/metabolism , Suprachiasmatic Nucleus/growth & development
14.
Somat Cell Mol Genet ; 23(2): 83-95, 1997 Mar.
Article in English | MEDLINE | ID: mdl-9330637

ABSTRACT

We have used representational difference analysis (RDA) for subtractive hybridization of oligo dT primed directionally cloned cDNA libraries from human inner ear tissue and a B-lymphoblast cell line. Two rounds of subtraction-amplification, followed by differential hybridization of selected clones led to the isolation of genes which were specific to the ear. Sequence analysis of randomly chosen clones revealed the presence of a histidine rich Ca2+ binding protein, human dynamin, collagen type 1A1, collagen type 2A1, SPARC, human growth hormone, and several specific genes which had no sequence homology in the data base. Furthermore, to apply these techniques for isolating genes specific to distinct inner ear structures and/or cell types of inner ear for which the starting tissue material is limiting, we have used a modified PCR based protocol to construct representative cDNA libraries. We have characterized a cDNA library constructed from small amounts of inner ear tissues recovered by ablative surgical procedure involving labyrinthectomy. The potential application of these protocols for isolating genes involved in hearing and deafness is discussed.


Subject(s)
DNA, Complementary/isolation & purification , Ear, Inner/metabolism , Gene Library , Adult , Animals , Cloning, Molecular , DNA, Complementary/chemistry , Ear, Inner/chemistry , Ear, Inner/surgery , Fetus , Humans , Mice , Poly A/chemistry , Poly A/isolation & purification , Polymerase Chain Reaction/methods , Random Allocation , Sequence Analysis, DNA , Sequence Homology, Nucleic Acid
15.
Genome Res ; 6(7): 633-8, 1996 Jul.
Article in English | MEDLINE | ID: mdl-8796351

ABSTRACT

A PCR method for uniform amplification of a mixture of DNA templates differing in GC content is described using the two enzyme approach (Klentaq1 and Pfu DNA polymerase) and a combination of DMSO and betaine. This method was applied to amplify the CGG repeat region from the fragile X region.


Subject(s)
Base Composition , DNA/genetics , Polymerase Chain Reaction/methods , Betaine , Carrier Proteins/genetics , DNA/chemistry , DNA-Directed DNA Polymerase , Dimethyl Sulfoxide , Female , Fragile X Syndrome/genetics , Humans , Major Histocompatibility Complex/genetics , Male , Membrane Proteins/genetics , Molecular Sequence Data , Organic Cation Transporter 1 , Receptors, Transferrin/genetics , Templates, Genetic , Trinucleotide Repeats
16.
Genomics ; 11(1): 115-23, 1991 Sep.
Article in English | MEDLINE | ID: mdl-1765370

ABSTRACT

We describe the construction and characterization of methylation-resistant sequence-tagged NotI linking clones specific for the X chromosome, referred to as NotI-BsuE linking clones. The approach consists of methylating the X-chromosome-specific cloned DNA with BsuE methylase (M. BsuE), an enzyme that methylates the first C residue in the CGCG sequence, followed by selection of the methylation-resistant NotI sites by insertion of a kanamycin-resistance gene in the clones cleavable by NotI. The frequent occurrence of NotI sites in CpG islands is expected to cause methylation of a large number of NotI sites with BsuE methylase, thereby rendering them resistant to NotI cleavage. Thus, the combination of M. BsuE and NotI yields less frequent cutting than the NotI alone. We have isolated, partially sequenced, and characterized 113 NotI-BsuE linking clones, and mapped 50 clones to various regions along the chromosome.


Subject(s)
DNA-Cytosine Methylases/metabolism , Deoxyribonucleases, Type II Site-Specific/metabolism , Genetic Linkage , Genomic Library , X Chromosome , Base Sequence , Cell Line , Cloning, Molecular , DNA/metabolism , DNA Probes , Humans , Molecular Sequence Data , Repetitive Sequences, Nucleic Acid
17.
Biochemistry ; 28(25): 9607-12, 1989 Dec 12.
Article in English | MEDLINE | ID: mdl-2514804

ABSTRACT

The mechanism of interaction of O-amino-D-serine (OADS) with sheep liver serine hydroxymethyltransferase (EC 2.1.2.1) (SHMT) was established by measuring changes in the enzyme activity, absorption spectra, circular dichroism (CD) spectra, and stopped-flow spectrophotometry. OADS was a reversible noncompetitive inhibitor (Ki = 1.8 microM) when serine was the varied substrate. The first step in the interaction of OADS with the enzyme was the disruption of enzyme-Schiff base, characterized by the rapid disappearance of absorbance at 425 nm (6.5 X 10(3) M-1 s-1) and CD intensity at 430 nm. Concomitantly, there was a rapid increase in absorbance and CD intensity at 390 nm. The spectral properties of this intermediate enabled its identification as pyridoxal 5'-phosphate (PLP). These changes were followed by a slow unimolecular step (2 X 10(-3) s-1) leading to the formation of PLP-OADS oxime, which was confirmed by its absorbance and fluorescence spectra and retention time on high-performance liquid chromatography. The PLP-OADS oxime was displaced from the enzyme by the addition of PLP as evidenced by the restoration of complete enzyme activity as well as by the spectral properties. The unique feature of the mechanism proposed for the interaction of OADS with sheep liver SHMT was the formation of PLP as an intermediate.


Subject(s)
Glycine Hydroxymethyltransferase/metabolism , Liver/enzymology , Serine/pharmacokinetics , Transferases/metabolism , Animals , Chromatography, High Pressure Liquid , Liver/drug effects , Oximes/pharmacokinetics , Sheep , Spectrophotometry
18.
Biochemistry ; 28(25): 9613-7, 1989 Dec 12.
Article in English | MEDLINE | ID: mdl-2611250

ABSTRACT

The interaction of aminooxy compounds such as aminooxyacetate (AAA), L-canaline, and hydroxylamine with sheep liver serine hydroxymethyltransferase (EC 2.1.2.1) was studied by absorption spectra and stopped-flow spectrophotometry and compared with the unique feature of interaction of O-amino-D-serine (OADS) with the enzyme [Baskaran, N., Prakash, V., Appu Rao, A. G., Radhakrishnan, A. N., Savithri, H. S., & Appaji Rao, N. (1989) Biochemistry (preceding paper in this issue)]. The reaction of AAA (0.5 mM) with the Schiff base of the enzyme resulted in the formation of pyridoxal 5'-phosphate (PLP) and was biphasic with rate constants of 191 and 19 s-1. The formation of the PLP-AAA oxime measured by decrease in absorbance at 388 nm on interaction of AAA with the enzyme had a rate constant of 5.2 M-1 s-1. On the other hand, the reaction of L-canaline with the enzyme was slower as measured by the disruption of enzyme-Schiff base than the reaction of OADS and AAA. In contrast, the formation of PLP as an intermediate could not be detected upon the interaction of hydroxylamine with the enzyme. The reaction of D-cycloserine with the enzyme was much slower (1.6 x 10(2) M-1 s-1) than the aminooxy compounds. These observations indicate that the aminooxy compounds that are structural analogues of serine (OADS, AAA, and canaline) formed PLP as an intermediate prior to the formation of oxime, whereas with hydroxylamine such an intermediate could not be detected.


Subject(s)
Acetates/pharmacology , Aminooxyacetic Acid/pharmacology , Glycine Hydroxymethyltransferase/metabolism , Liver/enzymology , Transferases/metabolism , Aminobutyrates/pharmacology , Animals , Glycine Hydroxymethyltransferase/antagonists & inhibitors , Hydroxylamines/pharmacology , Kinetics , Liver/drug effects , Sheep , Spectrophotometry
SELECTION OF CITATIONS
SEARCH DETAIL
...